Efficacy of poloxamer Р188 in restoring the metabolic profile in myelosuppression: a non-invasive nuclear magnetic resonance spectroscopy study
Biomeditsinskaya Khimiya · 2026-07 · 72 (3) · 207-219
DOI: 10.18097/pbmcr1662 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomeditsinskaya Khimiya, 2026. Verfasst von A V Kholina und 16 weiteren Autor:innen. Beteiligte Einrichtung: The Branch of the M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences in Pushchino, Pushchino, …. Hauptthemen laut MEDLINE: Poloxamer, Metabolome, Carboplatin, Bone Marrow. Die Arbeit nennt 23 Literaturangaben.
Abstract (Originalsprache)
Modern diagnostics in oncohematology is based on highly informative “gold standards” such as bone marrow biopsy, immunophenotyping, and cytogenetic analysis. The need to monitor the progression of the disease and the effectiveness of therapy requires the development of additional noninvasive approaches. One such approach is nuclear magnetic resonance spectroscopy (1H NMR spectroscopy); its key advantage is the ability to quickly and simultaneously identify many metabolites in biological body fluids to construct clinically relevant metabolomic profiles and provide an integrated picture of metabolic processes. The aim of the study was to identify key plasma metabolites altered due to carboplatin toxicity in the bone marrow of CBA mice and to evaluate the possibility of correcting these changes by oral administration of poloxamer P188. The animals were divided into 6 groups: intact control (CTR), a group with a pathology model without treatment (MYS), and 4 experimental groups receiving poloxamer P188 at doses from 10 mg/kg to 1000 mg/kg for 7 or 21 days. The plasma metabolic profile was analyzed by 1H NMR spectroscopy on days 8 and 22. A total of 36 metabolites were identified in plasma by 1H NMR spectroscopy, with statistically significant differences between groups found only for 15 compounds. A single intraperitoneal administration of carboplatin at a dose of 100 mg/kg caused significant metabolic shifts in the plasma of CBA mice associated with the development of myelosuppression: an increase in the concentrations of D-glucose-1-phosphate and lysine and a decrease in dimethylglycine, β-hydroxybutyrate, isobutyrate, and trimethylamine. Daily oral administration of P188 for 7 and 21 days in the myelosuppression model significantly affected the concentrations of key metabolites, resulting in increased isobutyrate and trimethylamine levels and decreased lysine levels. Thus, 1H NMR spectroscopy enabled us to identify characteristic metabolic disturbances in carboplatin-induced myelosuppression in CBA mice and demonstrate the efficacy of P188, which normalized key metabolites: isobutyrate, trimethylamine, and lysine. These data confirm the potential of using NMR metabolomics for noninvasive and personalized monitoring of therapy efficacy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Branch of the M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences in Pushchino, Pushchino, Russia.
- The Branch of the M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences in Pushchino, Pushchino, Russia; Hospital of the Pushchino Scientific Center of the Russian Aca…
- The Branch of the M.M. Shemyakin and Yu.A. Ovchinnikov Institute of Bioorganic Chemistry of the Russian Academy of Sciences in Pushchino, Pushchino, Russia; Pushchino branch of the Russian Biotechnological University, P…
- Institute of Mathematical Problems of Biology RAS - Branch of the Federal Research Center "Keldysh Institute of Applied Mathematics" of the Russian Academy of Sciences, Pushchino, Russia.
- Institute of Theoretical and Experimental Biophysics, Russian Academy of Sciences, Pushchino, Russia.
- Medical Emulsions LLC, Serpukhov, Russia.
Zitieren
APA
Kholina, A. V., Borozdina, N. A., Palikov, V. A., Dyachenko, I. A., Kravchenko, I. N., Dalevich, R. A., Pakhomova, I. A., Kazakova, E. N., Pankratova, N. M., Pankratov, A. N., Pozdnyakov, N. V., Murashev, A. N., Arshintseva, E. V., Pushkin, S. Y., Molchanov, M. V., Ziamko, V. Y., & Timchenko, M. A. (2026). Efficacy of poloxamer Р188 in restoring the metabolic profile in myelosuppression: a non-invasive nuclear magnetic resonance spectroscopy study. Biomeditsinskaya Khimiya, 72(3), 207-219. https://doi.org/10.18097/pbmcr1662
Vancouver
Kholina AV, Borozdina NA, Palikov VA, Dyachenko IA, Kravchenko IN, Dalevich RA, et al. Efficacy of poloxamer Р188 in restoring the metabolic profile in myelosuppression: a non-invasive nuclear magnetic resonance spectroscopy study. Biomeditsinskaya Khimiya. 2026;72(3):207-219. doi:10.18097/pbmcr1662
BibTeX
@article{Kholina2026,
author = {Kholina, A V and Borozdina, N A and Palikov, V A and Dyachenko, I A and Kravchenko, I N and Dalevich, R A and Pakhomova, I A and Kazakova, E N and Pankratova, N M and Pankratov, A N and Pozdnyakov, N V and Murashev, A N and Arshintseva, E V and Pushkin, S Yu and Molchanov, M V and Ziamko, V Yu and Timchenko, M A},
title = {Efficacy of poloxamer Р188 in restoring the metabolic profile in myelosuppression: a non-invasive nuclear magnetic resonance spectroscopy study},
journal = {Biomeditsinskaya Khimiya},
year = {2026},
volume = {72},
number = {3},
pages = {207--219},
doi = {10.18097/pbmcr1662}
}
EUVIMED